A prospective two-year examination of cognitive and behavioral correlates of provoked vestibulodynia outcomes by Davis, Seth et al.
Title: 
 
A prospective two-year examination of cognitive and behavioral correlates of 
provoked vestibulodynia outcomes 
 
 
Authors:  
 
Seth NP Davis PhD1, Sophie Bergeron PhD1, Katy Bois BSc1, Gentiana Sadikaj PhD2, 
Yitzchak M Binik PhD2, Marc Steben MD3 
 
Affiliations: 
 
1. Université de Montréal, Department of Psychology 
2. McGill University, Department of Psychology 
3. Centre Hospitalier de l’Univerisité de Montréal 
 
Corresponding author: 
 
Seth NP Davis 
1205 Rue Dr. Penfield 
Montreal, Quebec, Canada 
H3A 1B1 
seth.davis@mail.mcgill.ca 
514-398-5323 
 
Tables: 3 
 
Figures: 1 
  
Abstract 
 
Background: 
Provoked vestibulodynia (PVD) is a common genital pain disorder in women, which 
is associated with sexual dysfunction and lowered sexual satisfaction. A potentially 
applicable cognitive-behavioral model of chronic pain and disability is the fear-
avoidance model (FAM) of pain. The FAM posits that cognitive variables, such as 
pain catastrophizing, fear, and anxiety lead to avoidance of pain-provoking 
behaviors (intercourse), resulting in continued pain and disability. Although some of 
the FAM variables have been shown to be associated with PVD pain and sexuality 
outcomes, the model as a whole has never been tested in this population. An 
additional protective factor, pain self-efficacy, is also associated with PVD, but has 
not been tested within the FAM model.  
 
Aim: 
Using a two-year longitudinal design, we aimed to examine (1) whether initial levels 
(T1) of the independent FAM variables and pain self-efficacy were associated with 
changes in pain, sexual function and sexual satisfaction over the two-year time 
period, (2) the prospective contribution of changes in cognitive-affective  (FAM) 
variables to changes in pain, and sexuality outcomes and (3) whether these were 
mediated by behavioral change (avoidance of intercourse).  
 
Methods: 
A sample of 222 women with PVD completed self-report measures of FAM variables, 
self-efficacy, pain, sexual function and sexual satisfaction at Time 1 and at a two-
year follow-up. Structural equation modeling with latent difference scores was used 
to examine changes and to examine mediation between variables.  
 
Main Outcomes: 
Questionnaires included the Pain Catastrophizing Scale, McGill Pain Questionnaire, 
Trait Anxiety Inventory, Pain Self-Efficacy Scale, and Global Measure of Sexual 
Satisfaction, Female Sexual Function Index.  
 
Results: 
Participants who reported higher self-efficacy at T1 reported greater declines in 
pain, greater increases in sexual satisfaction, and greater declines in sexual function 
over the two time points. The overall change model did not support the FAM using 
negative cognitive-affective variables. Only increases in pain self-efficacy were 
associated with reductions in pain intensity. The relationship between changes in 
self-efficacy and changes in pain was partially mediated through changes in 
avoidance (more intercourse attempts). The same pattern of results was found for 
changes in sexual satisfaction as the outcome, and a partial mediation effect was 
found. There were no significant predictors of changes in sexual function other than 
T1 self-efficacy. 
 
Discussion: 
Changes in both cognitive and behavioral variables were significantly associated 
with improved pain and sexual satisfaction outcomes. However, it was the positive 
changes in self-efficacy that better predicted changes in avoidance behavior, pain 
and sexual satisfaction. Cognitive behavioral therapy is often focused on changing 
negative pain-related cognitions to reduce avoidance and pain, but the present 
results demonstrate the potential importance of bolstering positive self-beliefs as 
well. Indeed, before engaging in exposure therapies, self-efficacy beliefs should be 
assessed and potentially targeted to improve adherence to exposure strategies. 
  
Introduction 
Provoked vestibulodynia (PVD) is one of the most common genital pain conditions in 
women, with prevalence rates estimated around 12% 1. PVD is characterized by burning 
and cutting pain at the vulvar vestibule, which is generally elicited by pressure or rubbing to 
the area. Not surprisingly, PVD is associated with significant sexual dysfunction and 
lowered sexual satisfaction 2. Both biomedical and psychosocial factors have been 
hypothesized to be involved in the development and maintenance of PVD. Proposed 
biomedical pathways suggest that initial trauma to the genitalia may trigger inflammatory 
processes, pelvic floor 
muscle dysfunction, and other local changes, leading to increased pain sensitization and 
pain persistence 3. Alternative psychosocial explanations for the development and 
maintenance of PVD include maladaptive pain-related cognitions and behaviors that 
exacerbate pain and contribute to pain-related disability and sexual dysfunction 4.  At 
present, no convincing evidence justifies one single biomedical or psychosocial explanation. 
To add to the complexity of PVD, the triggers associated with the onset of the condition are 
often unclear and may be distinct from the factors that maintain and exacerbate it, and the 
predictors of pain outcomes can differ from those of sexuality outcomes, both of which are 
important to patient well-being.  Unfortunately, much of the research to date has focused on 
trying to identify factors associated with the development of this prevalent condition, with 
little work examining variables that may modulate the pain experience and associated 
sexual difficulties. Furthermore, the few published studies tend to be cross-sectional and 
therefore only provide partial information2,5.  The present two-year prospective study 
examined how changes in pain-related cognitions and emotions predicted changes in pain 
and sexual outcomes in women with PVD, and whether these changes were mediated 
through behavioral avoidance.   
 One of the most influential cognitive-behavioral theories of chronic pain and pain-related 
disability is the fear-avoidance model (FAM) (6,7. Although the model is most often applied 
to musculoskeletal pain, it may also be appropriate, in a modified form, to the prediction of 
PVD symptomatology. The FAM proposes a number of cognitive, affective, and behavioral 
steps that lead from pain to pain-related disability. Initially, individuals prone to pain 
catastrophizing tend to focus, ruminate and magnify the pain they experience. Catastrophic 
thinking about pain leads to fear of pain or anxiety, and more specifically, the belief that 
movement and movement-related pain will lead to re-injury. The behavioral effect of fear of 
pain and movement is an avoidance of potentially pain-inducing activities. The results of 
avoiding pain-inducing stimuli are that these beliefs are not challenged, which perpetuates 
the cycle and leads to disuse, disability, and depression. The FAM can also be conceptualized 
as a cycle by which disuse, disability, and depression lead to further pain.   
 
The FAM may be a useful model for explaining some of the cognitive-behavioral aspects of 
pain and disability in PVD. Indeed, higher levels of pain catastrophizing have been shown to 
be associated with increased PVD pain 8, which is the first step of the FAM. Furthermore, 
higher pre-treatment levels of catastrophizing have also been found to predict increased 
pain intensity after CBT treatment 9. Although fear of movement and behavioral avoidance 
of movement are not strictly applicable to PVD, avoidance of sexual intercourse is common 
in these women 10. This has previously been proposed as the circle of fear, by which fear of 
pain leads to avoidance of penetration 4. Avoidance may then lead to lowered sexual 
arousal, vaginal dryness, and pelvic floor tension, which in turn may result in greater pain 
during the sexual experience. Indeed, harm-avoidance has been shown to be elevated in 
women with vaginismus, another sexual pain disorder, as compared to controls, while 
women with dyspareunia had means that were intermediate between the two 11. Hence, it is 
reasonable to hypothesize that the FAM could apply to women with PVD as well. Fear of 
pain has been examined specifically in PVD, but was not found to be an independent 
predictor of pain or disability above and beyond catastrophizing, although this study did not 
take into account the sequential aspects of the FAM 8. However, another study showed that 
pain-related fear reduced sexual arousal in women with PVD as well as healthy controls 12. 
Thus the role of fear in PVD remains unclear to date. 
 
In addition to FAM variables, self-efficacy has recently been shown to be an important 
predictor of pain and disability in chronic pain sufferers 13, and sometimes a better 
predictor than FAM variables in low-back pain 14. Pain self-efficacy is conceptualized as the 
degree to which someone feels they can cope with difficult situations, in this case, situation 
that may provoke vulvo-vaginal pain. Better self-efficacy would mean a greater sense of 
being able to cope with pain, and feelings of being able to engage in activities despite pain. 
Self-efficacy has also been studied in women with PVD using cross-sectional designs 8 and 
as a predictor of treatment outcomes 9. In this randomized trial comparing cognitive-
behavioral therapy and a topical medical treatment, higher pre-treatment levels of self-
efficacy were a significant predictor of better sexual function (disability) at six-month 
follow-up, although not pain intensity. One possible explanation is that self-efficacy 
mediates the relationship between pain and disability by increasing patients’ engagement in 
the pain provoking behavior (sexual intercourse), thereby functioning to extinguish the 
association between pain and intercourse. 
 
Both FAM variables and self-efficacy have important implications for the treatment of PVD. 
One increasingly common treatment option for PVD is cognitive-behavioral therapy 15. The 
FAM dovetails nicely with cognitive-behavioral therapy as it points toward explicit negative 
cognitions to work on as well as behaviors to target by way of graduated exposure 
assignments. It also provides a temporal framework to work within, as the therapist must 
initially focus on challenging negative cognitions before explicitly addressing avoidance 
behaviors.  A similar model has been used in the cognitive-behavioral treatment of 
vaginismus, with improvements using both group therapy and bibliotherapy 16.  In 
particular, the actual behavioral engagement in the fear provoking stimuli (vaginal 
penetration) was shown to predict less fear of pain at later time points, and both fear of 
pain and penetration behaviors mediated outcomes 17. Furthermore, speed in treatment 
responding was mediated by fear of pain, such that late responders had higher levels of fear 
of pain than early responders. These results, however, were for women with vaginismus, 
and may not apply to PVD. Nonetheless, in another CBT treatment trial for women with 
PVD, higher perceived pain control was related to more improvement in pain outcomes, but 
only in women who reported an ability to engage in intercourse after the treatment 15. This 
suggests that perceived control, which shares much conceptual overlap with self-efficacy, is 
related to behavior. 
 
An examination of FAM cognitive-affective variables and self-efficacy is not novel in genital 
pain. Several studies have demonstrated that fear of pain, self-efficacy, and pain 
catastrophizing are all related to pain intensity and sexual function/satisfaction 8,9,11,17. 
There are, however, a number of areas where this research can be expanded upon to refine 
cognitive-behavioral theoretical conceptualizations of PVD and to improve utility for clinical 
applications. One issue is the cross-sectional design of much of the previous research. While 
cross-sectional data give important information about cognitive factors that are related to 
pain and sexual dysfunction, they do not allow us to determine whether changes in these 
cognitive variables are related to changes in outcomes. Second, these data assume a 
relationship between cognitive and behavioral variables, but within the PVD literature, 
these have not been tested in a sequential manner as proposed by the FAM. Doing so will 
allow this research to inform the development of targeted therapeutic interventions. 
Finally, to our knowledge, behavioral avoidance has never been measured in the context of 
the FAM as applied to PVD. Instead, previous studies on PVD assume that cognitions related 
to avoidance lead to actual behavioral avoidance, although this relationship has never been 
tested. The present study aimed to rectify this by measuring the number of attempts at 
intercourse as an indicator of avoidance and examining their association with pain-related 
cognitions and emotions. 
 
The goals of the present two-year prospective study were three-fold. First, we aimed to 
examine whether initial levels of the independent FAM variables and pain self-efficacy 
predicted changes in pain and sexuality outcomes.  Second, using change scores over two 
years, we aimed to examine whether changes in cognitive-affective variables would predict 
changes in pain and sexual outcomes over the same two-year period. Third, we aimed to 
examine whether the relationship between changes in cognitive-affective variables and 
changes in pain/sexuality outcomes was mediated by changes in behavioral avoidance as 
proposed by the FAM. 
 
It was hypothesized that higher initial (T1) levels of catastrophizing, fear, and anxiety 
would be associated with less changes in pain, sexual function, and sexual satisfaction, while 
higher initial levels of self-efficacy would be associated with more changes. It was further 
hypothesized that decreases in catastrophizing, fear, and anxiety, as well as increases in 
self-efficacy, would be associated with increases in sexual satisfaction, and decreases in pain 
and sexual dysfunction over the two-year period, and that these changes would be 
accounted for by increases in number of attempts at sexual intercourse (i.e. decreases in 
behavioral avoidance). 
 
Methods 
Participants 
Participants were recruited during clinic visits to either gynecologists or other health 
professionals, as a well as through newspaper in a large urban center and website 
advertisements. Because this was part of a larger study on couples, women were required 
to be in a relationship. If women indicated an interest in the study, they were screened 
either face-to-face or by telephone to determine eligibility. The specific inclusion criteria for 
women were: a) pain during intercourse that was subjectively distressing, occurred on 80% 
of intercourse attempts, and lasted > 1 year; b) pain limited to intercourse and other 
activities that caused pressure to be exerted on the vestibule; c) if recruited through a 
gynecologist, severe pain in one or more vestibular locations during the cotton swab test; d) 
married or cohabiting with a partner for at least 6 months. The exclusion criteria were: a) 
vulvar pain not clearly linked to intercourse or pressure to the vestibule; b) presence of 
major medical or psychiatric illness, active infection, deep dyspareunia, physician diagnosed 
vaginismus, dermatologic lesion, pregnancy, age < 18 years old. 
 
Procedure 
This study was approved by the Centre Hospitalier de l’Univeristé de Montréal Institutional 
Review Board All participants gave written informed consent. If women were interested in 
participating, they were either given a questionnaire package in person at the gynecology 
clinic or, in the case where they were recruited via an advertisement, the package was sent 
to their home. They were asked to complete it on their own and without the help of their 
partner. Two years later, a research assistant contacted all participants that participated at 
Time 1. If they agreed to participate in the Time 2 data collection, they were sent one 
package each via regular mail and were asked to complete the measures as per the same 
initial instructions. If participants were now single or had a new partner, they were 
excluded from the present analysis, as behavioral measures of intercourse attempts 
required consistency of partners. 
  
Measures 
Dependent variables: 
Pain intensity 
Pain intensity was measured using a Visual Analogue Scale by asking participants to 
estimate their average vulvo-vaginal pain over the past month. Participants rated pain 
intensity on a scale from 0-10, with 0 representing no pain and 10 representing the worst 
pain ever. The VAS has good validity and reliability in measuring many different types of 
pain 18. This method of pain measurement is sensitive to treatment effects in PVD 19, and 
correlates well with other measures of pain 8 in PVD.  
 
Sexual Satisfaction  
The Global Measure of Sexual Satisfaction (GMSEX) 20 was used to measure sexual 
satisfaction. The GMSEX is a five-item measure that assesses satisfaction and affective 
descriptors regarding the sexual relationship with one’s partner. Each item is rated on a 7-
point Likert scale, with higher scores indicating greater satisfaction. The scale has good 
psychometric properties including good reliability and excellent validity 21.   The Cronbach 
alpha in the present sample was 0.90. 
 Sexual Function 
The Female Sexual Function Index (FSFI) is a well-validated measure of sexual function in 
women 22. The scale is divided into 6 dimensions: desire, arousal, lubrication, orgasm, 
sexual satisfaction, and pain, with higher scores indicating better sexual function. The 
present study calculated a total FSFI score without the pain subscale, as the aim was to 
measure aspects of sexual function other than pain. Inclusion of the pain subscale would 
likely lead to inflated correlations with other measures of pain. The Cronbach’s alpha for the 
present sample was 0.80. 
 
Independent Variables: 
Pain Catastrophizing 
The Pain Catastrophizing Scale (PCS) 23 is a well validated and widely used measure of pain 
catastrophizing from the chronic pain literature. In the present study, women were asked to 
fill out the PCS regarding the thoughts and feelings they had when experiencing pain during 
intercourse. Although there are subscales of rumination, magnification, and helplessness, 
the total score was used in the present study. Higher scores indicate more catastrophizing. 
Cronbach’s alpha in this sample was 0.87. 
 
Pain Self-efficacy 
The Painful Intercourse Self-Efficacy Scale (PISES) is a scale adapted from the Arthritis Self-
Efficacy Scale 24. The original scale is widely used and cited in the general pain literature, 
and has been found to be reliable and valid in arthritis populations 24.  The adapted version 
has been used in previous research in women with PVD and was predictive of pain-related 
variables 9, with higher scores indicating more self-efficacy. Previous studies using an 
adapted version of the scale have found a Cronbach’s alpha of 0.89, and the Cronbach alpha 
for the present study was 0.90. 
 
Anxiety 
The Spielberger State-Trait Anxiety Inventory (STAI) 25 was used to measure anxiety. This is 
a 40-item, well-known, and well-validated measure of anxiety with excellent psychometric 
properties. There are two subscales: State and Trait. Only the trait subscale was used in the 
present study, as the questionnaire was completed at home, hence state anxiety could not 
be accounted for. Higher scores indicate more anxiety. The Cronbach alpha for the trait 
scale in the present sample was 0.93.   
 
Fear 
Each participant filled out the McGill Pain Questionnaire (MPQ)26 , which is a widely used 
measure of affective, cognitive, and sensory descriptors of pain. Participants were asked to 
fill out the questionnaire specifically regarding their pain during intercourse.  Participants 
are asked to choose pain-related adjectives from a list to describe their pain. There are 
three fear-related adjectives that may be chosen, and participants may choose between 0-3. 
The number of fear-related pain adjectives chosen was used as the fear score, and higher 
scores indicated more fear. The MPQ has been shown to be a reliable and valid measure of 
many types of pain 18. 
 
Behavioral avoidance 
Participants were asked how many times in the past month they had attempted to have 
sexual intercourse with vaginal penetration. The actual number of attempts, successful or 
not, was taken as the behavioral measure of avoidance, with a lower number of attempts 
being indicative of more avoidance. 
 
Analysis strategy 
To examine the influence of changes in cognitive, affective and behavioral variables on the 
changes in pain, sexual satisfaction and sexual function, a Latent Difference Score (LDS) 
approach was employed 27,28.  In contrast to observed difference score models, the LDS 
model accommodates the estimation of a reliable index of change by modeling change in 
perfectly reliable scores in time-ordered data 29.  LDS modeling permits the examination of 
within-person change and individual differences in this within-person change 30. 
Specifically, within-person change is represented by a latent construct (i.e., LDS) indexing 
the difference between adjacent scores in time-ordered data. Individual differences in this 
within-person change are modeled as a function of the individual differences in the level of 
the (1) same variable at the prior measurement occasion (i.e., auto-regressive lagged effect), 
and (2) other time-varying (e.g. sexual satisfaction) and time-invariant covariates (e.g. 
gender). Furthermore, this within-person change between two adjacent measurement 
occasions can be used as predictor of other time-varying variables thereby permitting an 
examination of the effect of the dynamic change in one process on other parallel change 
processes.  
 
First, for each of the variables, we constructed auto-regressive lagged paths from the same 
variable at T1 on the LDS, depicting change in that variable between the two occasions. 
Next, the LDSs in pain, sexual satisfaction, and sexual dysfunction were examined in relation 
to (1) cognitive, affective and behavioral variables at T1, and (2) by the LDSs occurring 
between the two occasions in each cognitive, affective and behavioral variable. Thus, these 
cross-variable lagged effects represent the influences of the cognitive-affective and 
behavioral variables’ (1) T1 and (2) LDSs on the dependent variables (i.e., LDSs in pain, 
sexual satisfaction, and sexual function), controlling for the auto-regressive lagged effects 
T1 on the dependent variables. Finally, we re-estimated the model by co-varying out the 
influence of pain duration on LDSs in each of the dependent and independent variables.  
 
We examined mediation in the model by constructing indirect effects of the difference 
scores in cognitive-affective variables on difference scores in pain, sexual satisfaction, and 
sexual function through the LDS in the behavioral avoidance variable (number of attempts).  
 
Analyses were conducted using the Mplus software package (Version 7; Muthen & Muthen, 
1998 – 2012) and the maximum likelihood estimator with standard errors that are robust 
to non-normality of observations and to missing data. Fit of the model was examined using 
the root mean square error of approximation (RMSEA), standardized root mean square 
residual (SRMR), and comparative fit index (CFI). RMSEA and SRMR values of .08 or less 31 
and CFI values over .90 32 indicate good model fit.  
 
Results 
Sample characteristics 
A total of 317 participants completed the questionnaires at Time 1 (T1), and 222 at Time 2 
(T2), for a retention rate of 70.1%. Therefore, the final data analyzed included 222 women. 
There were no significant differences between T1 variables between women who 
completed and women who did not complete T2. Of these 222 women, 104 had been 
diagnosed with PVD by their gynecologist, and the remainder (118) met criteria for PVD 
based on the telephone screening. There were no differences in any of the T1 variables 
based on the source of recruitment (gynecologist or other). The mean age of the sample at 
T1 was 31.0 years (range = 18-68, SD = 10.9). The mean pain duration at T1 was 5.6 years 
(range = 0.5 – 43.8, SD = 6.2), and the mean pain intensity at T1 was 7.1/10 (range = 1-10, 
SD – 1.7). Seven participants left the T1 pain intensity blank and were coded as missing data 
for further analyses. All women were in a relationship at T1 and the mean relationship 
duration was 6.8 years (range = 0.5-38.4, SD = 7.4). The majority (97.3%) identified 
culturally as Québécois or Canadian , and had at least completed high school (88.9%).  All 
women who did not engage in intercourse were asked the reason for not engaging in 
intercourse, and all indicated that pain or fear of pain were at least one of the potential 
reasons. 
 
The means and standard deviations for each dependent and independent variable are 
provided in Table 1. The observed means for pain, catastrophizing, fear, and anxiety 
decreased over the two-year period. The means for self-efficacy, sexual satisfaction, number 
of attempts, and sexual function increased.  As expected, there were positive correlations (at 
the same time point) between the FAM cognitive-affective variables with the exception of 
anxiety and fear at T1. The FAM variables were all negatively correlated with self-efficacy. 
These cognitive-affective variables were also correlated in the expected direction with the 
number of attempts in the last month, with the exception of fear at T1 and T2 and anxiety at 
T1. Finally, FAM cognitive-affective variables (catastrophizing, fear, and anxiety) were 
generally positively correlated with pain and negatively correlated with sexual satisfaction, 
while self-efficacy and number of attempts were generally negatively correlated with pain, 
and positively correlated with sexual satisfaction. Sexual function was inconsistently 
correlated with cognitive, affective and behavioral variables. All bivariate correlations are 
available in Table 1.  In addition, the sociodemographic variables of age, pain duration, 
relationship duration, age of first pain, and years of education were correlated with the 
independent and dependent variables. None were correlated above 0.30, so it was decided 
not to co-vary them out of further analyses. 
 
Main Effects Model 
Goodness of fit indices for the model indicated good fit (RMSEA = 0.06, SRMR = .03, CFI = 
0.99). We first examined the auto-regressive, lagged effects of each variable at T1 on the 
LDS for that variable. All the effects were significant and with a negative coefficient, 
indicating that, compared to participants with lower scores, those who scored higher on the 
initial status (i.e. T1) in each of the independent (catastrophizing, fear, anxiety, self-efficacy, 
and avoidance) and dependent (pain, sexual satisfaction, and sexual function) variables are 
expected to report lower scores at the subsequent time point (i.e. T2).  
 
The first part of the model that was examined was the degree to which initial level (T1) of 
the independent variables were associated with the degree to which the dependent 
variables changed (LDS). To do so, cross-variable lagged effects of the independent 
variables at the initial status (T1) on the three dependent variables (LDS in pain, sexual 
satisfaction and sexual function) were examined (Table 2). Findings indicate that 
participants who reported higher self-efficacy at T1 reported greater declines in pain, 
greater increases in sexual satisfaction, and greater declines in sexual dysfunction over the 
two time points. None of the T1 values for any of the FAM variables (catastrophizing, fear, 
and anxiety) were significantly associated with LDS in pain, satisfaction, sexual function, or 
number of attempts.  
 
The second part of the model that was examined was the degree to which changes (LDS) in 
the independent variables were associated with changes (LDS) in the dependent variables. 
To do so, cross-variable lagged effects of the LDS in independent variables (self-efficacy, 
catastrophizing, fear, and anxiety) on the three dependent variables (LDS in pain, sexual 
satisfaction and sexual function) were examined (Table 3). Controlling for other effects in 
the model, LDS in self-efficacy and number of attempts was associated with LDS in pain 
such that participants who reported increases in self-efficacy and number of attempts (i.e. a 
positive change score) between the two measurement occasions experienced greater 
declines in pain between T1 and T2: PISES: B = -0.52, p < 0.001 and number of attempts: B = 
-.12, p < .05. Controlling for other sources of influence in the model, LDS in self-efficacy and 
LDS in number of attempts was also associated with LDS in sexual satisfaction. Participants 
who reported increases in self-efficacy and number of attempts from T1 to T2 experienced 
increases in sexual satisfaction between T1 and T2 (PISES: B = 0.45, p < 0.001: Number of 
attempts: B = .20, p < .001). Finally, none of the LDSs for the independent variables 
(catastrophizing, fear, anxiety, and self-efficacy) or behavioral avoidance (number of 
attempts) predictors was significantly related to changes in sexual function (Table 3). 
 
Mediational Analysis 
The final portion of the model tested the degree to which the association between pain, 
sexual satisfaction and sexual function by FAM cognitive-affective variables (fear, 
catastrophizing, anxiety, and self-efficacy) was accounted for by behavioral avoidance 
(number of attempts). The examination of the indirect effects indicated that LDS in number 
of attempts (estimated indirect effect = .03, p < .05)(see figure 1) accounted for the relation 
between LDS in self-efficacy and LDS in sexual satisfaction. More specifically, participants 
who reported greater LDS in self-efficacy, experienced an increased number of attempts 
which, in turn, was associated with these participants’ increases in sexual satisfaction 
between the two occasions.  
 
Discussion 
Findings from the present two-year prospective study show that only higher initial levels of 
self-efficacy were significantly associated with improved outcomes for pain and sexual 
satisfaction, and contrary to our hypothesis, of a worse outcome for sexual function. In 
addition, contrary to our hypothesis, changes in the FAM cognitive-affective variables were 
generally not associated with outcomes. while increases in pain self-efficacy were 
significantly associated with both decreases in pain and increases in sexual satisfaction. 
These findings are partially consistent with current cognitive-behavioral theories of chronic 
pain, as well as with results from studies examining the influence of cognitive-behavioral 
variables on pain and sexuality endpoints in women with PVD 8,9, whereby only some of the 
expected predictors were significant. The mediation hypothesis that cognitive-affective 
variables and self-efficacy were associated with pain and sexual outcomes through changes 
in behavioral avoidance was only supported for self-efficacy. 
 
There are a number of implications of these findings for the applicability of the FAM model 
to women with PVD. Despite the widespread use of the FAM in explaining pain-related 
disability in chronic pain, FAM cognitive-affective variables (catastrophizing, fear, and 
anxiety) were not the most important factors associated with outcomes, including pain, in 
the present study. Specifically, both initial levels and changes in FAM cognitive-affective 
variables were not associated with changes in pain, sexual satisfaction or sexual function. 
Furthermore, the FAM is proposed as a sequential model, by which FAM cognitions and 
emotions influence outcomes through behavioral avoidance of pain-inducing stimuli. 
Therefore, it is important to test not only whether FAM cognitions are associated with final 
outcomes, but also whether they are associated with behaviors, and whether these 
behaviors, in turn, account for changes in outcomes.  The behavior-mediated model using 
FAM variables was not supported, as none of the mediation models of FAM variables 
predicting pain and sexual outcomes through changes in number of attempts at intercourse 
were significant. In addition, none of the FAM cognitive-affective variables were associated 
with behavioral avoidance (number of attempts). In contrast to the FAM variables, self-
efficacy was significantly associated with behavioral avoidance. Changes in self-efficacy 
from T1 to T2 were associated with changes in number of attempts in a positive direction. 
Furthermore, increase in number of attempts was significantly associated with both 
decreases in pain and increases in sexual satisfaction. Tests of indirect effects found that 
they partially accounted for sexual satisfaction. This indicates that the associated between 
changes in sexual satisfaction and self-efficacy may be partially accounted for by changes in 
number of attempts at intercourse. This is directly in line with the sequential portion of the 
FAM, except that instead of negative cognitions and emotions (catastrophizing, fear, and 
anxiety) leading to increased avoidance, the positive cognition of self-efficacy was 
associated with decreased avoidance, which in turn was associated with better sexual 
satisfaction. 
 
Self-efficacy was associated with behavior and outcomes throughout the model. Increases in 
self-efficacy were associated with both decreases in pain and increases in sexual 
satisfaction. Furthermore, self-efficacy at T1 was associated with changes in all outcome 
variables (pain, sexual satisfaction, and sexual function), although in the opposite direction 
that was expected for sexual function. Finding self-efficacy to more highly associated with 
outcomes than FAM cognitions and emotions is not entirely surprising. Recent studies in 
chronic pain have demonstrated that self-efficacy is a powerful predictor of pain and pain-
related disability 13,33. Furthermore, in women with PVD, using cross-sectional designs, self-
efficacy has been found to be the only significant predictor of sexual function, although 
catastrophizing was a better predictor of pain 8. In a CBT treatment trial, both initial levels 
of self-efficacy as well as initial levels of FAM variables predicted changes in outcomes 9. 
Both the present study and these previous studies find self-efficacy to be important; 
however, the present study failed to find the same support for FAM cognitions and 
emotions. There are a number of reasons this may have occurred. In particular, our 
question of interest was how changes in independent variables predicted changes in 
dependent variables, as opposed to initial levels of the T1 independent variables predicting 
T2 endpoints. While these are similar concepts, they are theoretically different models, as 
the former is dynamic, while the latter is static. Just because initial levels are high does not 
mean they will necessarily change over time and subsequently be associated with changes 
in outcome. Indeed, using initial levels to predict outcomes at T2 may only identify those 
participants who do not change over time. For example, high catastrophizers may remain 
high catastrophizers, and have little decrease in pain because of it. It may be that FAM 
cognitions are less amenable to change than self-efficacy without specific treatment.  
Therefore, one would not expect to see changes in FAM cognitions be significantly 
associated with changes in outcome variables if these variables remain static over time. On 
the other hand, analyzing change scores allows an examination of what changes are 
associated with improvements (LDS) in outcomes; in the present study, this was self-
efficacy. 
 
In the present sample, almost none of the cognitive-affective or behavioral variables were 
associated with sexual function.  The only exception was initial levels of self-efficacy, which 
surprisingly was associated with changes in sexual function in the opposite direction than 
was expected. This is in contrast with previous research which has found that sexual 
functioning is positively related to self-efficacy in women with PVD 8,9. This difference could 
be explained by previous research’s use of the full FSFI scale score, which includes a 
subscale for pain. Therefore, it is likely that if pain decreased, so would sexual dysfunction, 
as measured by the FSFI, and the two scales would be correlated. In our sample, the pain 
subscale of the FSFI was omitted to obtain a measure of sexual function that was not 
obscured by pain levels. Another potential problem is the scoring of the FSFI. Previous 
criticisms of the FSFI are that women who are not engaging in sexual activity are forced to 
score zero on many items 34. This may be a problem in PVD research considering avoidance 
of sexual activity is an important aspect of PVD. In the present sample, mean FSFI scores at 
both time points were below a clinical cutoff (21) 35 for sexual dysfunction, which may 
suggest a potentially exaggerated lowering of scores due to avoidance. Prior 
recommendations have been made to only include women engaging in sexual activity on the 
FSFI 34, but this would likely remove a large, clinically significant, and non-random portion 
of our sample.  
 
Another explanation is simply that changes in sexual function were not influenced by the 
predictor variables of interest. The FAM cognitive-affective variables and self-efficacy are 
measured in relation to pain, and may not have had an effect on other aspects of sexual 
function (desire, arousal, and lubrication). Furthermore, resolution of pain does not 
necessarily mean that one will automatically have more desire for their partner, or become 
lubricated more easily. In fact, pain and sexuality outcomes are not always correlated 
among one another 5,36. Despite this possibility, sexual satisfaction outcomes did improve 
when measured using the GMSEX, which does not have the same scoring issues as the FSFI 
for women with PVD. It is apparent that teasing apart the relationship between genital pain 
and sexual dysfunction in women with PVD will remain a needed focus of future research 
and the FSFI may not be the best scale with which to do this. There is certainly debate as to 
whether genital pain should be classified as a sexual dysfunction or a pain disorder 37, 
although it will remain a sexual dysfunction in the DSM-5 38,39.  
 
Treatment implications 
These findings are clinically relevant for CBT treatment of women with PVD. At present, 
CBT therapy for women with PVD is often focused on challenging maladaptive cognitions 
regarding pain, such as catastrophizing, fear, and anxiety. Cognitive work is generally 
combined with assigning exercises of graduated vaginal penetration exposure (touch, 
fingers, and graduated dilator sets), with the ultimate goal of achieving penetrative sexual 
intercourse. The significant finding that behavior mediated the impact of self-efficacy on 
pain and sexual satisfaction supports the importance of engaging in exposure exercises. The 
present findings, however, highlight the need for improving patients’ self-efficacy as a first 
step in reducing pain and increasing sexual satisfaction. Because exposure exercises are 
often aversive to patients, these findings demonstrate the importance of bolstering self-
efficacy before behavioral assignments are given to improve adherence to the homework. It 
is also worth noting that self-efficacy is a positive cognition that clinicians can aim to 
improve, rather than a maladaptive cognition that clinicians aim to extinguish. This may 
provide a unique positive psychology alternative that nicely complements the present 
treatments focused on the FAM.   
 
Strengths 
Although this is not the first study to examine cognitive, affective and behavioral variables 
in PVD 8,9,12,15, it does extend these findings in several important ways. The first is by 
exploring a meditational analysis of how cognitive, affective and behavioral variables relate 
to one another, as well as to outcomes. This study also improves upon previous studies by 
using actual attempts at engagement in sexual intercourse as the measure of avoidance. 
Many previous studies of PVD assume that fear and avoidance cognitions are related to 
actual behavioral avoidance. By measuring reported engagement in sexual intercourse, we 
were able to demonstrate the meditational aspects of behavior in our model. Finally, the 
present study measured how changes in predictor variables predicted changes in outcomes, 
as opposed to using single time point measurements. In terms of creating effective 
cognitive-behavioral treatments, it is important to know that changing maladaptive 
cognitions and behaviors leads to changes in outcomes. By measuring change scores (LDS), 
the present study was able to do so.  
 
Study limitations 
In addition to the strengths of the present study, there are a number of ways that it could be 
improved. A mediation analysis using two time points does not allow causal or truly 
mediation conclusions to be made from the data. By adding a third (or more) time point(s) 
to the study, it would have been possible to test whether early changes in cognitions led to 
later changes in behaviors, followed by changes in outcomes, in a sequential manner.  Using 
only two time points, it is possible that changes in pain led to reductions in avoidance 
behaviors and changes in cognitions, instead of vice versa. Indeed, other studies in chronic 
pain have found that the FAM does not always hold up in a sequential analysis 40. The 
potential applicability of the study could also be stronger if it were part of a CBT treatment 
trial. It is possible that changes in FAM variables are actually more important than changes 
in self-efficacy, but are less likely to change without therapy. Perhaps targeting these 
variables specifically in therapy would have led to them being significantly associated with 
outcomes. Another limitation was that our measure of anxiety was a general measure, and 
our measure of fear was based on affective descriptions of pain. Specifically, the use of the 
fear adjectives of the MPQ has not been previously validated as a measure of fear. Although 
the measure of anxiety and fear correlated as expected with other FAM cognitions in the 
expected directions, they could have been improved by measuring the actual emotions of 
fear and anxiety as related to pain due to intercourse. For example, in musculoskeletal pain, 
the Tampa Scale of Kinesiophobia is often used to measure fear of movement and the pain 
and injury it is believed to cause 41. To our knowledge, this scale does not exist for PVD.  
Nonetheless, these results may not be as directly applicable to other examinations of the 
FAM model because of the difference in outcome measures used. In addition, the behavioral 
measure of sexual attempts relies on recall, which may be biased. Finally, the present study 
was only conducted in women who were in long-term romantic relationships and hence 
may not necessarily apply to those who are single. 
 
Conclusions 
In conclusion, cognitive, affective and behavioral factors do play a role in the experience of 
pain and sexual health of women with PVD. Specifically, changes in self-efficacy appear to be 
the best predictor of changes in pain and sexual satisfaction over a two-year time period. 
Furthermore, these changes are mediated by changes in avoidance behavior. These findings 
demonstrate the importance of targeting self-efficacy early in treatment to improve 
outcomes and to help reduce avoidance of potentially pain provoking behaviors.  
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